Literature DB >> 444786

Monoamine oxidase (MAO) of platelets, plasma, lymphocytes and granulocytes in schizophrenia.

P A Bond, R L Cundall, I R Falloon.   

Abstract

Monoamine oxidase (MAO) levels in plasma, platelets, lymphocytes and granulocytes have been compared in schizophrenics and controls using three substrates. No significant difference was found between MAO levels in controls and the schizophrenic group as a whole, but platelets and lymphocytes of the latter (tyramine or benzylamine substrate) showed greater variation and in some cases higher values than controls, irrespective of treatment. Schizophrenics who experienced auditory hallucinations had significantly lower MAO levels in lymphocytes and platelets than those who did not.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444786     DOI: 10.1192/bjp.134.4.360

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Clinical variables and platelet mao in schizophrenia.

Authors:  I Sharma; A Kumar; J P Chansouria; S L Varma
Journal:  Indian J Psychiatry       Date:  1991-10       Impact factor: 1.759

2.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

Review 3.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.